Biotechnology at Inter American University of Puerto Rico-Arecibo

A debt-to-earnings ratio of 0.51 sits in reasonable territory for a biotech degree, though the picture here warrants careful scrutiny. Based on comparable biotechnology bachelor's programs nationally, first-year earnings around $47,000 paired with estimated debt of $24,125 suggests manageable repayment—but there's an unsettling twist in the data. Four years out, median earnings drop to $39,913, roughly $7,000 less than the first-year estimate. This earnings decline is unusual and raises questions about career trajectory or whether graduates are finding work that fully utilizes their biotechnology training.

The estimated debt figure notably exceeds both the Puerto Rico median ($13,779) and sits above the national benchmark ($20,618), which matters in a context where 81% of students receive Pell grants. For families already stretching financially, that additional $10,000+ in borrowing compared to other PR programs is real money. The challenge is that we're working entirely with estimates here—no actual outcome data exists for this specific program's graduates, making it difficult to assess whether this particular school delivers on biotechnology's promise or struggles with placement.

The bottom line: If your child is set on biotech and this is the most accessible option, the numbers aren't alarming—but that backward earnings movement and higher-than-typical Puerto Rico debt should prompt direct questions to the school about graduate outcomes, internship pipelines, and why their data isn't being reported.